# Feasibility Study of a Dose Increase by a Boost of Curietherapy in Pulse Dose Rate (PDR) Associated With the Extern Radiotherapy in Prostate Cancer

> **NCT01039038** · PHASE2 · TERMINATED · sponsor: **Centre Francois Baclesse** · enrollment: 50 (estimated)

## Conditions studied

- Prostate Cancer With Intermediate Risk

## Interventions

- **RADIATION:** curietherapy and radiotherapy

## Key facts

- **NCT ID:** NCT01039038
- **Lead sponsor:** Centre Francois Baclesse
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2009-09
- **Primary completion:** 2011-11
- **Final completion:** 2011-11
- **Target enrollment:** 50 (ESTIMATED)
- **Why stopped:** lack of recruitment
- **Last updated:** 2011-11-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01039038

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01039038, "Feasibility Study of a Dose Increase by a Boost of Curietherapy in Pulse Dose Rate (PDR) Associated With the Extern Radiotherapy in Prostate Cancer". Retrieved via AI Analytics 2026-07-10 from https://api.ai-analytics.org/clinical/NCT01039038. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
